Literature DB >> 18349446

Spectrum of CT findings after radiofrequency ablation of hepatic tumors.

Mi-hyun Park1, Hyunchul Rhim, Young-sun Kim, Dongil Choi, Hyo K Lim, Won Jae Lee.   

Abstract

Image-guided radiofrequency (RF) ablation has been used to treat both resectable and nonresectable hepatic tumors. A precise imaging assessment of the therapeutic response and of any complications is mandatory after ablation. Contrast material-enhanced ultrasonography, computed tomography (CT), and magnetic resonance imaging all may be useful for this assessment. At most institutions, a three-phase contrast-enhanced CT examination is performed immediately or within 1 month after RF ablation to assess the technical success of treatment. If ablation was technically successful, three-phase CT may be repeated at 3-month intervals for evaluation of tumor recurrence. The typical CT finding in the zone subjected to RF ablation is an area of low attenuation that encompasses the tumor and an ablative margin. However, the appearance of the ablative zone may vary greatly, depending on the success of treatment and the time elapsed after the procedure. Ringlike enhancement representing benign reactive hyperemia around the ablation zone, central high-attenuation areas representing greater cellular disruption, and tiny air bubbles frequently are seen at immediate follow-up CT but usually have disappeared by the first or second follow-up examination. The successfully ablated zone gradually involutes. The appearance of the zone differs when residual tumor tissue or local tumor progression is present. Immediate or delayed complications also may be seen at follow-up CT. Radiologists must be familiar with both typical and atypical CT findings and their clinical significance. (c) RSNA, 2008.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18349446     DOI: 10.1148/rg.282075038

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  25 in total

1.  Contrast-enhanced C-arm CT evaluation of radiofrequency ablation lesions in the left ventricle.

Authors:  Erin E Girard; Amin Al-Ahmad; Jarrett Rosenberg; Richard Luong; Teri Moore; Günter Lauritsch; Jan Boese; Rebecca Fahrig
Journal:  JACC Cardiovasc Imaging       Date:  2011-03

2.  Intra-operative ultrasound elasticity imaging for monitoring of hepatic tumour thermal ablation.

Authors:  Mark G Van Vledder; Emad M Boctor; Lia R Assumpcao; Hassan Rivaz; Pezhman Foroughi; Gregory D Hager; Ulrike M Hamper; Timothy M Pawlik; Michael A Choti
Journal:  HPB (Oxford)       Date:  2010-12       Impact factor: 3.647

3.  Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT.

Authors:  S Tokunaga; M Koda; T Matono; T Sugihara; T Nagahara; M Ueki; Y Murawaki; S Kakite; E Yamashita
Journal:  Br J Radiol       Date:  2011-03-08       Impact factor: 3.039

4.  Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation.

Authors:  A Brouquet; J-N Vauthey; B D Badgwell; E M Loyer; H Kaur; S A Curley; E K Abdalla
Journal:  Br J Surg       Date:  2011-05-03       Impact factor: 6.939

5.  Radiofrequency Ablation of Hepatic Tumor: Subjective Assessment of the Perilesional Vascular Network on Contrast-Enhanced Computed Tomography Before and After Ablation Can Reliably Predict the Risk of Local Recurrence.

Authors:  Sireesha Yedururi; Silanath Terpenning; Sanjay Gupta; Patricia Fox; Sooyoung Shin Martin; Claudius Conrad; Evelyne M Loyer
Journal:  J Comput Assist Tomogr       Date:  2017 Jul/Aug       Impact factor: 1.826

6.  Evaluation of cancer treatment in the abdomen: Trends and advances.

Authors:  Silanath Peungjesada; Hubert H Chuang; Srinivasa R Prasad; Haesun Choi; Evelyne M Loyer; Yulia Bronstein
Journal:  World J Radiol       Date:  2013-03-28

7.  Ablative margin states by magnetic resonance imaging with ferucarbotran in radiofrequency ablation for hepatocellular carcinoma can predict local tumor progression.

Authors:  Masahiko Koda; Shiho Tokunaga; Kennichi Miyoshi; Manabu Kishina; Yuki Fujise; Jun Kato; Tomomitsu Matono; Yoshikazu Murawaki; Suguru Kakite; Eijiro Yamashita
Journal:  J Gastroenterol       Date:  2013-01-22       Impact factor: 7.527

8.  [Criteria for radiological assessment of therapy response: criteria-based appraisal].

Authors:  M D'Anastasi; N A Schramm; M F Reiser; A Graser
Journal:  Radiologe       Date:  2013-04       Impact factor: 0.635

9.  Contrast enhanced ultrasound: Roles in immediate post-procedural and 24-h evaluation of the effectiveness of thermal ablation of liver tumors.

Authors:  M F Meloni; A Andreano; F Zimbaro; M Lava; S Lazzaroni; S Sironi
Journal:  J Ultrasound       Date:  2012-09-29

10.  Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.

Authors:  E Ronan Ryan; Constantinos T Sofocleous; Heiko Schöder; Jorge A Carrasquillo; Sadek Nehmeh; Steven M Larson; Raymond Thornton; Robert H Siegelbaum; Joseph P Erinjeri; Stephen B Solomon
Journal:  Radiology       Date:  2013-04-05       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.